"10.1371_journal.ppat.1003520","plos pathogens","2013-08-01T00:00:00Z","Stephanie Traub; Alexandra Nikonova; Alan Carruthers; Rebecca Dunmore; Katherine A Vousden; Leila Gogsadze; Weidong Hao; Qing Zhu; Katie Bernard; Jie Zhu; Michael Dymond; Gary R McLean; Ross P Walton; Nicholas Glanville; Alison Humbles; Musa Khaitov; Ted Wells; Roland Kolbeck; Andrew J Leishman; Matthew A Sleeman; Nathan W Bartlett; Sebastian L Johnston","National Heart and Lung Institute, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Centre for Respiratory Infection, Imperial College London, London, United Kingdom; MedImmune Ltd, Cambridge, United Kingdom; MedImmune LLC, Gaithersburg, Maryland, United States of America; AstraZeneca, Charnwood, United Kingdom; NRC Institute of Immunology FMBA, Moscow, Russia","Conceived and designed the experiments: SLJ NWB ST MAS AC RK AJL AH TW. Performed the experiments: ST NWB RPW NG AN LG JZ GRM AC RK AH RD QZ WH KB MD. Analyzed the data: ST NWB SLJ AC RD RK MAS AJL AH. Contributed reagents/materials/analysis tools: MAS KAV MK. Wrote the paper: ST NWB SLJ MAS KAV.","The following authors (AC, RD, KAV, WH, QZ, AH, RK, MAS, KB, MD, TW, AJL) are full time employees of MedImmune Ltd. or MedImmune LLC, wholly owned subsidiaries of Astrazeneca PLC. As employees they also receive shares and share options in the Astrazeneca Group. During the course of the study the following authors (AJL, TW) were employees of Astrazeneca PLC and received shares and share options. Astrazeneca is a global pharmaceutical company that conducts basic research and clinical trials in respiratory diseases such as severe asthma and chronic obstructive pulmonary disease. This work was in part funded by MedImmune and Astrazeneca PLC. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.","2013","08","Stephanie Traub","ST",22,TRUE,9,16,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
